February 13, 2025 - 14:29

WASHINGTON, D.C. — U.S. Senator Alex Padilla (D-Calif.) took to the Senate floor today to express his strong opposition to the nomination of Robert F. Kennedy Jr. as the head of the Department of Health and Human Services (HHS). Padilla highlighted significant concerns regarding the potential public health consequences should Kennedy be confirmed for the position.
In his remarks, Padilla emphasized the importance of appointing a leader at HHS who prioritizes science-based public health policies. He criticized Kennedy for his controversial views and actions, which he argued could undermine trust in health institutions at a time when the nation is still grappling with the aftermath of the COVID-19 pandemic. The senator's comments reflect a growing unease among some lawmakers about the implications of Kennedy's nomination for public health strategy and policy.
Padilla's speech underscores the critical nature of the HHS role, particularly in addressing ongoing health challenges and ensuring the safety and well-being of the American public.
November 4, 2026 - 18:41
Shelter-in-Place Order Rescinded After Incident Near Yale Health CenterAuthorities have lifted the shelter-in-place order that was issued following a shooting incident near the Yale Health Center. Fortunately, no injuries were reported, and university officials...
November 4, 2026 - 07:43
Political Changes Create Opportunities for Dividend StocksWashington has just handed investors a plot twist. A recent Democratic sweep of Congress, combined with new concerns about debt ceiling negotiations and the impact on Treasury yields, is shifting...
November 3, 2026 - 22:04
Study Finds Shorter Radiation Treatment Beneficial for Breast Cancer PatientsBruce Haffty, MD, associate Vice chancellor for Cancer Programs at Rutgers Cancer, recently discussed the findings of a significant study published in the Journal of Clinical Oncology. This...
November 3, 2026 - 01:18
Behavioral Health Investors Shift Focus from Expansion to Market DepthIn 2021, the behavioral health dealmaking market was booming. Double-digit multiples were commonplace and operators raced to open up shop in as many new regions as possible. The strategy was simple...